Nicox’s Partner Ocumension Therapeutics Initiates Zerviate Phase 3 Clinical Trial in China
Tháng Một 4, 2021
Không có phản hồi
Nicox SA announced that its partner, Ocumension Therapeutics, has initiated a phase 3 clinical trial in China with Zerviate, the first and only topical ocular